Austin neuromodulation startup raises $25M Series A for non-invasive ultrasound therapy
The company is developing non-invasive ultrasound treatments aimed at immune-mediated diseases.
Who's raising, who's writing the checks, and what the term sheets really say.
The company is developing non-invasive ultrasound treatments aimed at immune-mediated diseases.